by 
The decongestant market includes nasal decongestants that provide rapid and effective relief from nasal congestion associated with common colds, hay fever, sinusitis and other upper respiratory infections. They work by constricting swollen blood vessels in the nasal passages, thus reducing inflammation and allowing better air flow through nasal passages.
The global decongestant market is estimated to be valued at US$ 4,710.4 Mn in 2024 and is expected to exhibit a CAGR of 18.% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the decongestant market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc. Johnson & Johnson and Pfizer Inc. dominate the global market.
The growing prevalence of respiratory disorders like common cold, sinusitis, allergies etc. is driving the demand for decongestant drugs globally. According to World Health Organization (WHO), over 1.5 billion people suffer from sinusitis every year.
Major pharmaceutical companies are expanding their decongestant product portfolios and presence globally especially in emerging markets of Asia Pacific and Latin America to tap the high growth opportunities.
Market key trends
Self-medication for cold, cough and nasal congestion has increased significantly over the years. Easy availability of decongestants in the form of tablets, capsules and syrups without prescription is contributing to high sales volumes through retail pharmacy channels globally. Self-medication reduces patient healthcare costs and provides immediate relief from symptoms but requires adequate self-dosing by patients.
Porter’s Analysis
Threat of new entrants: New players will find it difficult to establish themselves due to high manufacturing costs and high legal compliance requirements.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutable products like cough mixture.
Bargaining power of suppliers: Suppliers have high bargaining power due to specialized raw materials required and differentiated products.
Threat of new substitutes: Substitutes like cough mixtures pose threat but decongestant are preferred for quick relief.
Competitive rivalry: Intense competition exists between major players to dominate market share.
Geographical regions with high market value:
North America region dominates the market and holds around 50% value share owing to growing patient pool of respiratory disorders.
Fastest growing geographical region:
Asia Pacific region is expected to witness highest growth during forecast period due to increasing healthcare expenditure, rising disposable income, growing awareness about nasal decongestants.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
